AMANDA ROSENAUER: Open Payments
NPI 1265873251 · LA GRANGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 21 payments from 14 companies in 2025. Trend: 2023 $567 · 2024 $620 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| DePuy Synthes Sales Inc. | 1 | $37 |
| Corcept Therapeutics | 2 | $32 |
| ABBVIE INC. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
| Antares Pharma, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
Products named: JARDIANCE, SHINGRIX, MONOVISC, TRELEGY ELLIPTA, Korlym, VRAYLAR, Veozah, FARXIGA.
Industry payments across TX — which companies pay providers there.
